RNO 0.00% 4.0¢ rhinomed limited

Ann: Rhinoswab clinical program update, page-8

  1. 109 Posts.
    lightbulb Created with Sketch. 122
    My comments state facts!

    For 7 years this company has gone backwards. The same CEO rubbished everyone before him and still has not delivered a cash flow positive quarter.

    Another capital raise is due as mathowa has eluded to.

    We are in the midst of the biggest bull market in history and this company has gone backwards. Why you may ask? A smart man would say that Johnson is an average salesman, that’s why. And an overpaid one also.

    The company has huge potential but not with him at the helm.
 
watchlist Created with Sketch. Add RNO (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.